FSRH CEU statement: Drospirenone 4mg Progestogen-only Pill (Slynd®)

Posted 10 January 2024

Date: 10 Jan 2024

Type: FSRH Clinical Guidance and Clinical Statements

A new drospirenone progestogen-only pill (DRSP POP) Slynd® is now available in the UK.

CEU recommendations and guidance about DRSP POP can be found in the FSRH Progestogen Only Pills Guideline (2022). The CEU statement provides a brief summary of key information.

The full statement is available below to view and download.